Technology 57 of 266
Molecular simulation
8 EIC Accelerator winners build on Molecular simulation, 1% of the classified companies, in 3 sectors and 5 industries.
8
Companies
3
Sectors
5
Industries
6
Countries
0%
Exits
25%
Show signs of scaling
Sectors
- Health3 (38%)
- Digital and computing4 (50%)
- Materials and chemicals1 (13%)
Industries
Used together with
Other technologies of the same companies
Companies per year of first award
2019
2020
2021
2022
2023
2024
- Molecular simulation
Show the numbers
| Companies | Molecular simulation | |
|---|---|---|
| 2019 | 2 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 4 | 4 |
| 2024 | 0 | 0 |
What happened to them (8 of 8 checked)
- Active8 (100%)
- Exit0 (0%)
- Failed0 (0%)
- Other0 (0%)
Signs of scaling
- Scaling2 (25%)
- Not scaling2 (25%)
- Scaling unclear4 (50%)
Keywords
- Battery development
- Battery electrolytes
- Binding free energy
- Binding kinetics
- Biocatalysis
- Chemical engineering
- Chemical libraries
- Computational chemistry
- Computational drug design
- Computer-aided drug design
- Covalent drugs
- Crystal structure prediction
- Drug development
- Drug discovery
- Enzyme engineering
- Fault-tolerant quantum computing
- Fine chemicals
- Inflammation
- Materials discovery
- Molecular dynamics
- Oncology
- Pharmaceutical intermediates
- Pharmaceutical research
- Physical properties
- Polymorphs
- Process simulation
- Quantum chemistry
- Thermodynamic modelling
- Virtual screening
All 8 companies using Molecular simulation
| Company | Project | Industry | Country | Cut-off | Funding | Status | Rasph |
|---|---|---|---|---|---|---|---|
| Compular AB | COMPULARAdvanced Simulation Software With Patented Method Optimised For Battery Development | Enterprise software | Sweden | November 2023 | Blended finance | Active | Deep dive |
| Biosimulytics Limited | biosim m2mBioSim M2M: Molecules to Medicine | Life science tools | Ireland | March 2023 | Grant first | Active | Deep dive |
| BEIT Spolka z ograniczona odpowiedzialnoscia | COMFTQUAEnabling efficient computation on fault tolerant quantum computers | Quantum technology | Poland | January 2023 | Grant first | Active | Deep dive |
| Kvantify ApS | KvasirAcceleratorThe first utility-oriented, agnostic software platform for quantum-centric drug discovery | Quantum technology | Denmark | January 2023 | Grant first | Active | Deep dive |
| Qubit Pharmaceuticals SAS | ATLASNext generation HPC/QC in silico drug discovery platform leveraging the latest advances in high-performance and quantum computing | Biopharmaceuticals | France | June 2021 | Blended finance | Active | Deep dive |
| PHARMACELERA SL | PharmScreen2Holistic Quantum Mechanics Based Platform to Accelerate Drug Discovery | Biopharmaceuticals | Spain | January 2020 | Grant only | Active | Deep dive |
| Hafnium Labs ApS | HafniumFaster and smarter chemical R&D with accurate physical property predictions | Enterprise software | Denmark | June 2019 | Grant only | Active | Deep dive |
| ZYMVOL BIOMODELING SL | UNLOCK-EDDUNLOCKing next generation computer-guided Enzyme Discovery and Design. | Industrial biotechnology | Spain | April 2019 | Grant only | Active | Deep dive |